- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 317/34 - Oxygen atoms
Patent holdings for IPC class C07D 317/34
Total number of patents in this class: 99
10-year publication summary
|
8
|
8
|
9
|
3
|
10
|
2
|
4
|
8
|
3
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Corsair Pharma, Inc. | 37 |
12 |
| Theravance Biopharma R&D IP, LLC | 460 |
5 |
| Agilent Technologies, Inc. | 2634 |
4 |
| BASF SE | 20892 |
3 |
| Industrial Technology Research Institute | 5086 |
3 |
| The Regents of the University of California | 19857 |
2 |
| Syngenta Participations AG | 1907 |
2 |
| Anhui University of Science and Technology | 186 |
2 |
| Board of Trustees of Michigan State University | 1181 |
2 |
| Mark Quang Nguyen | 9 |
2 |
| Pfizer Ireland Pharmaceuticals | 41 |
2 |
| Shenzhen Capchem Technology Co., Ltd. | 287 |
2 |
| Solvay Specialty Polymers Italy S.p.A. | 755 |
2 |
| Mind Medicine Inc. | 99 |
2 |
| LG Chem, Ltd. | 17594 |
1 |
| Boehringer Ingelheim Pharma GmbH & Co. Kg | 584 |
1 |
| ExxonMobil Research And Engineering Company | 2585 |
1 |
| Evonik Degussa GmbH | 1537 |
1 |
| Massachusetts Institute of Technology | 10030 |
1 |
| Shin-Etsu Chemical Co., Ltd. | 5632 |
1 |
| Other owners | 48 |